Pay in 4 interest-free payments of $470.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Both enantiomers in the racemic mixture exhibit antineoplastic activity
is an investigational drug for the acute conversion of atrial fibrillation
CTEP Derivative dose dependently increases the drinking time
2-d]pyrimidin-4-one hydrochloride
Trabectedin - CAS# 114899-77-3 pone Both enantiomers in the racemicTrabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug